Empowering Girls: Success of Nigeria’s HPV Vaccine Rollout Explained | Nigeria Health Watch, Nov 2024

HPV Vaccine Rollout in Nigeria: A Focus on Clarity and Engagement

In Nigeria, awareness of the Human Papillomavirus (HPV) vaccine is growing, especially in Kwara State. Local mothers like Haulat Abdulfatah and Rukayyat Temitope are leading the way. They brought their daughters for vaccinations despite initial concerns about the vaccine’s safety. Both mothers recognized the importance of protecting their daughters from cervical cancer. Temitope noted her awareness of the vaccine’s benefits, highlighting the need to convince other hesitant caregivers.

The HPV vaccine aims to protect girls from cervical cancer, which causes approximately 8,000 deaths annually in Nigeria. The campaign for the HPV vaccine began in 2015, but the official rollout started in October 2023, targeting 7.7 million girls. The Coordinating Minister of Health, Professor Muhammad Ali Pate, emphasized the significance of the vaccine in reducing preventable deaths.

Cervical cancer is the third most common cancer among Nigerian women aged 15 to 44. The vaccine, recommended by the World Health Organization (WHO) since 2009, offers significant protection against this disease. The cost of the HPV vaccine is a concern, as it is the most expensive vaccine in Nigeria. The country opted for the single-dose Gardasil-4 vaccine to ease logistics in reaching school-aged girls.

Implementation of the vaccine rollout involved several stakeholders, with the National Primary Healthcare Development Agency (NPHCDA) coordinating efforts. The rollout happened in two phases. Despite facing challenges like misinformation and logistical issues, the initiative successfully vaccinated over 12 million girls during the campaign.

Community engagement, particularly by traditional leaders, played an essential role in the vaccine’s success. Leaders like Alhaji Abdulmumin Ayoku rallied support for the initiative, helping to ensure high vaccination rates. Effective communication strategies also engaged various stakeholders, including schools and local organizations.

The campaign faced challenges, including parental consent and vaccine refusal from certain groups. Parents, especially fathers, often needed more awareness about the vaccine’s benefits. Efforts in educating male caregivers are crucial for improving vaccine uptake.

Despite these hurdles, Kwara State emerged as a leader in HPV vaccination, achieving over 117% coverage of the target population. The HPV vaccine is now integrated into the National Programme on Immunisation. Moving forward, it will be available at government facilities, emphasizing the importance of accessibility and continued education on vaccines.